BRANDL TALOS advises GraphTx on additional USD 5 million financing

Press release • Corporate Law & Transactions from Stephan Strass, Markus Reinfeld, Alyssa Nimmervoll

BRANDL TALOS has advised Austrian techbio company Graph Therapeutics on an additional USD 5 million financing, led by Paris-based venture capital firm daphni with participation of the existing investors SquareOne Venture Capital, Merantix Capital and NAVEC Investment Management.

BRANDL TALOS has advised Austrian techbio company Graph Therapeutics on an additional USD 5 million financing, led by Paris-based venture capital firm daphni with participation of the existing investors SquareOne Venture Capital, Merantix Capital and NAVEC Investment Management.

Graph is advancing its internal drug discovery programs across multiple inflammatory and immune-mediated disease indications. The financing will support the transition from platform development to advancing proprietary therapeutic programs toward the clinic, while further expanding the company’s platform capabilities and strategic partnership opportunities. Congratulations to the entire Graph Therapeutics team on this achievement!

The BRANDL TALOS team consisted of Stephan Strass, Markus Reinfeld and Alyssa Nimmervoll.

The team

Stephan Strass

Array
(
    [0] => WP_Term Object
        (
            [term_id] => 5
            [name] => Attorney at Law
            [slug] => attorney-at-law
            [term_group] => 0
            [term_taxonomy_id] => 5
            [taxonomy] => category
            [description] => 
            [parent] => 0
            [count] => 15
            [filter] => raw
        )

    [1] => WP_Term Object
        (
            [term_id] => 4
            [name] => Partner
            [slug] => partner
            [term_group] => 0
            [term_taxonomy_id] => 4
            [taxonomy] => category
            [description] => Partner
            [parent] => 0
            [count] => 11
            [filter] => raw
        )

)

Partner / Venture Capital & Start Ups, Corporate Law & Transactions, BioTech & Lifescience

Stephan advises innovative start-ups, institutional and strategic investors and other companies on acquisitions, financing rounds, joint ventures and exit transactions with a focus on highly regulated industries such as life sciences, biotech and leisure & entertainment. He further specializes in commercial transactions in the life science and biotech sector, including university spin-offs, strategic collaborations, patent and technology license agreements and IP purchase transactions.

He has co-authored commentaries on the EU Merger Act and the Investment Fund Act, and is the author of many academic publications.

University of Vienna, Faculty of Law (Mag. iur. 2015)
Harvard Law School, Master of Laws (LL.M. 2019)

Markus Reinfeld

/ Corporate Law & Transactions, Venture Capital & Start Ups, Real Estate Law

Markus has many years of experience in the transactional field, with a focus on start-ups, venture capital, private equity, and other M&A transactions. In addition to his legal practice, Markus is the co-founder of a legal tech tool as well as a fintech company in the social business sector.

He is the author and co-editor of the Sample Collection of IT Contracts and the author of several other academic publications.

Santa Clara University, Master of Laws (LL.M. 2014)
University of Vienna,, Master of Laws (LL.M. 2013)
University of Vienna, Faculty of Law (Mag, iur 2011)
University of Vienna,, Political Science (BA)

Alyssa Nimmervoll

Array
(
    [0] => WP_Term Object
        (
            [term_id] => 21
            [name] => Associate
            [slug] => associate
            [term_group] => 0
            [term_taxonomy_id] => 21
            [taxonomy] => category
            [description] => 
            [parent] => 0
            [count] => 23
            [filter] => raw
        )

)

Associate / Corporate Law & Transactions

Alyssa is part of our team since 2026.

WU Vienna University of Economics and Business (LL.M. 2025)

Latest insights into
Corporate Law & Transactions

BRANDL TALOS advises shareholders of contextflow on the sale to 4DMedical

Press release • Corporate Law & Transactions from Roman Rericha, Markus Arzt, Adrian Zuschmann, Nina Atanasovska

BRANDL TALOS advises shareholders of contextflow on the sale to 4DMedical

BRANDL TALOS advises founders on the sale of HAKOM to Volue

Press release • Corporate Law & Transactions from Roman Rericha, Adrian Zuschmann

BRANDL TALOS advises founders on the sale of HAKOM to Volue

BT advises investor consortium on record-breaking seed financing of Emmi AI

Press release • Venture Capital & Start Ups from Roman Rericha, Adrian Zuschmann

BT advised investors 3VC, Speedinvest, Serena and PUSH on the seed financing round of Emmi AI. With a total investment of EUR 15 million, the round marks the largest seed funding ever raised by a startup in Austria.